Arizona Gov. Doug Ducey has signed three bills targeting abortion providers, including one requiring them to follow outdated federal guidelines for the most common abortion drug and prescribe it at much higher doses than needed.
The law boldly defies new FDA rules implemented this week on abortion drugs.
The signing of the bill, Senate Bill 1324, is likely to jump-start a federal court case that blocked a previous version of the legislation.
The bill bars doctors from prescribing the drug commonly known as RU-486 after seven weeks of pregnancy and requires it to be taken only at Food and Drug Administration-approved doses in effect until this week. It also requires the two doses of the drug to be taken at a clinic, while providers now send the patient home with the second pill to be taken days after the first.
Courts blocked a similar 2012 law, and a federal injunction remains in place against that legislation.
In a signing statement Thursday, the Republican governor said the Legislature acted in good faith in approving the legislation to deal with the lawsuit brought by abortion providers.
“In such a case, I will always stand with those advocating life,” Ducey wrote. “I recognize that given the unexpected actions of the FDA, some changes may need to be made in a later bill, and I stand ready to consider those changes when they reach my desk.”
The legislation was backed by the antiabortion group the Center for Arizona Policy, whose president, Cathi Herrod, is a powerful force at the Republican-controlled Legislature. In a statement, the organization said: “Center for Arizona Policy stands with Gov. Ducey on his statement and will be working with legislative leaders to respond appropriately.”
Ducey also signed two other bills targeting abortion or abortion providers. One, Senate Bill 1474, bars abortion providers from transferring fetal tissue for use in research. Planned Parenthood’s Arizona affiliate said it doesn’t provide fetal tissue for research.
Planned Parenthood Arizona spokeswoman Jodi Liggett said the governor should have vetoed the abortion medication legislation, especially because he recognizes it likely will need to be immediately revamped to deal with the new FDA guidelines. She said she expected legislation to fix the issue to emerge quickly.
“By ‘fix it,’ we take it to mean they’ll just lock the new label into place in perpetuity, which is pretty silly and is all about face-saving and not about any rational policy at all,” Liggett said. “That’s a lot of time and effort just to appease Cathi Herrod.”